Please fill in the form below and we’ll get back to as soon as possible

Your Name

Your Email

Telephone Number

Your Enquiry

Home » Sale of pharmaceutical company for a seven-figure plus deferred consideration

Sale of pharmaceutical company for a seven-figure plus deferred consideration

PostedMarch 2018

We worked on the share sale of a pharmaceutical distributor on the sale of their entire issued share capital to a large multinational eye healthcare manufacturer looking to diversify its portfolio. The sale involved negotiating and amending the terms of a share purchase agreement prepared by a team of US based lawyers. It was complicated by the need to make a provision for an on-going consultancy arrangement between the sellers and purchaser. The deal also required the incorporation of deferred consideration provisions tied to the future success of products sold by the company or any of its affiliates. This meant the value of the deal was heavily tied to the subsequent sales and we addressed this within the transaction documents. From the date of instruction to the completion date, the sale was completed in under a month.

Research firm Legacy Foresight is predicting that charities’ income from legacies could fall by as much as 27% this year, as a result of the coronavirus crisis. Partner @AndrewY_DO has put together some key information for charities to think about >> https://bit.ly/307jdGB

It's not too late to sign up to our FREE #employmentlaw update webinar TOMORROW at 7.30pm with @hrinherts. Employment partner @LAttrup will cover the most up to date details around the #furlough scheme in response to COVID-19. Register here: https://bit.ly/2TENgSi

Thanks to Emma @StAlbansCOC @alwoodgate for allowing us to speak at this morning's webinar, very well organised as always! Thank you to our speakers @m417ead @EWillatts @kerrigan_mk. All our latest info & updates on the current situation can be found here https://bit.ly/2XsPO8b

Senior lawyers @m417ead, @kerrigan_mk & @EWillatts are speaking TOMORROW at the @StAlbansCOC webinar. They will be advising local businesses on how they can manage a return to work in response to COVID-19. It's not too late to register >>>https://bit.ly/36BFQEk

Research firm Legacy Foresight is predicting that charities' income from legacies could fall by as much as 27 per cent this year, as a result of the coronavirus crisis. We have put together some key information for you to think about, and the charity sector team at Debenhams Ottaway, would be very happy to talk to you to see if we can help.

Understand how much cash...

With huge numbers of people forced to work from home due to social distancing measures, COVID-19 has changed the way we work. Businesses with IT systems that have been able to support remote working on a scale that will not previously have been envisaged may be considering a permanent move away from office-based working. In this article, we suggest ways in which business tenants can offload ...

Debenhams Ottaway is the trading name of Debenhams Ottaway LLP, a Limited Liability Partnership registered in England and Wales under number OC373542. The registered office is Ivy House, 107 St Peters Street, St Albans, Hertfordshire, AL1 3EW. A list partners is available upon request. The term partner is used to refer to a member of Debenhams Ottaway LLP or an employee or consultant with equivalent standing and qualifications. The firm is authorised and regulated by the Solicitors Regulation Authority under numbers 567621 and 568531.